Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Rimbault Abraham A, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA. Simioni S, et al. Among authors: muller h. Neurology. 2013 Feb 5;80(6):553-60. doi: 10.1212/WNL.0b013e3182815497. Epub 2013 Jan 23. Neurology. 2013. PMID: 23345635 Free article. Clinical Trial.
Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma: A Comprehensive Analysis of Individual Patient Data from Randomized GHSG Trials.
Bröckelmann PJ, Müller H, Fuchs M, Gillessen S, Eichenauer DA, Borchmann S, Jacob AS, Behringer K, Momotow J, Ferdinandus J, Böll B, Yang X, Kobe C, Eich HT, Baues C, Klapper W, Engert A, Borchmann P, von Tresckow B. Bröckelmann PJ, et al. Among authors: muller h. Ann Oncol. 2024 Dec 18:S0923-7534(24)04988-3. doi: 10.1016/j.annonc.2024.12.009. Online ahead of print. Ann Oncol. 2024. PMID: 39706337 Free article.
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.
Koscielniak E, Ljungman G, Kazanowska B, Niggli F, Sparber-Sauer M, Handgretinger R, Zimmermann M, Boos J, Blank B, Hallmen E, Teichert von Lüttichau I, Schmid I, Fröhlich B, Müller HL, Behnisch W, Ladenstein R, Scheer M, Vokuhl C, von Kalle T, Blattmann C, Bielack S, Klingebiel T. Koscielniak E, et al. Among authors: muller hl. EClinicalMedicine. 2024 Nov 29;78:102957. doi: 10.1016/j.eclinm.2024.102957. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39687431 Free PMC article.
Is human oversight to AI systems still possible?
Holzinger A, Zatloukal K, Müller H. Holzinger A, et al. Among authors: muller h. N Biotechnol. 2024 Dec 13;85:59-62. doi: 10.1016/j.nbt.2024.12.003. Online ahead of print. N Biotechnol. 2024. PMID: 39675423 Free article.
6,065 results